World's Best Scientists 2026 revealed!
Manoel Barral-Netto

Manoel Barral-Netto

Award Badge
Immunology
Brazil
2026

D-Index & Metrics

Immunology

D-Index
72
Citations
15336
World Ranking
2254
National Ranking
11

Medicine

D-Index
72
Citations
15373
World Ranking
19899
National Ranking
61

Manoel Barral-Netto publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Manoel Barral-Netto sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 285 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Manoel Barral-Netto D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Manoel Barral-Netto sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Brazil Leader Award
  • 2025 - Research.com Immunology in Brazil Leader Award
  • 2023 - Research.com Immunology in Brazil Leader Award
  • 2022 - Research.com Immunology in Brazil Leader Award

Overview

Manoel Barral-Netto is affiliated with the Oswaldo Cruz Foundation in Brazil. Their academic work is primarily situated within the field of Medicine, with a specific focus on Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology, Health, and Modeling and Simulation. This multidisciplinary approach addresses pressing health challenges, often related to infectious agents and public health dynamics.

The scientist's research topics cover several major areas, including:

  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy
  • COVID-19 Epidemiological Studies
  • COVID-19 Clinical Research Studies
  • Mosquito-borne Diseases and Control
  • Data-Driven Disease Surveillance
  • Viral Infections and Vectors

Manoel Barral-Netto has contributed to a number of notable publications in high-impact venues. Some of their recent papers are:

  • Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil, 2020, published in Ciência & Saúde Coletiva
  • Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic, 2021, published in Science
  • Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil, 2022, published in Nature Medicine
  • Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study, 2021, published in The Lancet Regional Health - Americas
  • Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study, 2022, published in The Lancet Infectious Diseases

The scientist frequently publishes in several key venues, which include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • The Lancet Infectious Diseases
  • JMIR Public Health and Surveillance
  • Ciência & Saúde Coletiva

Collaborative work is an important aspect of their research, with frequent co-authors such as Viviane Boaventura, Thiago Cerqueira-Silva, Maurício L. Barreto, Gerson Oliveira Penna, and Ricardo Khouri. These collaborations have contributed to advancing knowledge in epidemiological modeling, vaccine effectiveness, and infectious disease surveillance, particularly in the Brazilian public health context.

Best Publications

  • Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

    Manoel Barral-Netto;Aldina Maria Prado Barral;Aldina Maria Prado Barral;Cari E. Brownell;Yasir A. W. Skeiky

  • Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.

    Lewis F Buss;Carlos A Prete;Claudia M M Abrahim;Alfredo Mendrone

  • Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease.

    Barral A;Pedral-Sampaio D;Grimaldi Júnior G;Momen H

  • Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.

    Roberto Badaro;Ernesto Falcoff;Fernando S. Badaro;Edgar M. Carvalho

  • Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance

    Bruno B. Andrade;Bruno B. Andrade;Antonio Reis-Filho;Antonio Reis-Filho;Sebastião M. Souza-Neto;Sebastião M. Souza-Neto;Jorge Clarêncio;Jorge Clarêncio

  • Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis

    Aldina Barral;Manoel Barral-Netto;Elenita C. Yong;Cari E. Brownell

  • CD4+CD25+ T Cells in Skin Lesions of Patients with Cutaneous Leishmaniasis Exhibit Phenotypic and Functional Characteristics of Natural Regulatory T Cells

    Ana P. Campanelli;Ana M. Roselino;Karen A. Cavassani;Marcelo S. F. Pereira

  • Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

    Unknown

  • Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection

    Fernanda O. Novais;Rômulo C. Santiago;André Báfica;Ricardo Khouri

  • Immunologic Markers of Clinical Evolution in Children Recently Infected with Leishmania donovani chagasi

    Edgar M. Carvalho;Aldina Barral;Diana Pedral-Sampaio;Manoel Barral-Netto

  • Human immune response to sand fly salivary gland antigens: a useful epidemiological marker?

    Aldina Barral;Eduardo Honda;Arlene Caldas;Jackson Costa

  • Balance of IL-10 and Interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis

    Arlene Caldas;Arlene Caldas;Cecília Favali;Dorlene Aquino;Dorlene Aquino;Vera Vinhas

  • Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines.

    Viviane S. Boaventura;Claire S. Santos;Cristina Ribeiro de Barros Cardoso;José de Andrade

  • Chemokines in host–parasite interactions in leishmaniasis

    Maria Jania Teixeira;Maria Jania Teixeira;Clarissa Romero Teixeira;Clarissa Romero Teixeira;Bruno Bezerril Andrade;Bruno Bezerril Andrade;Manoel Barral-Netto;Manoel Barral-Netto

  • Leishmanial infection: analysis of its first steps. A review

    M. C. de Almeida;V. Vilhena;A. Barral;Manoel Barral-Netto

  • Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

    R. L. A. Bottrel;W. O. Dutra;F. A. Martins;B. Gontijo

  • Revisiting proteus: do minor changes in lectin structure matter in biological activity? Lessons from and potential biotechnological uses of the Diocleinae subtribe lectins

    B. S. Cavada;T. Barbosa;S. Arruda;T. B. Grangeiro

  • Seroconversion against Lutzomyia longipalpis Saliva Concurrent with the Development of Anti–Leishmania chagasi Delayed-Type Hypersensitivity

    Regis B. Gomes;Cláudia Brodskyn;Cláudia Brodskyn;Camila I. de Oliveira;Jackson Costa

  • CD8(+) Granzyme B(+)-Mediated Tissue Injury vs. CD4(+)IFNγ(+)-Mediated Parasite Killing in Human Cutaneous Leishmaniasis

    Claire da Silva Santos;Claire da Silva Santos;Viviane Boaventura;Viviane Boaventura;Cristina Ribeiro Cardoso;Natalia Tavares;Natalia Tavares

  • Haematophagous arthropod saliva and host defense system: a tale of tear and blood

    Bruno Bezerril Andrade;Clarissa Romero Teixeira;Clarissa Romero Teixeira;Aldina Maria Prado Barral;Aldina Maria Prado Barral;Manoel Barral-Netto;Manoel Barral-Netto

  • Lymphadenopathy as the First Sign of Human Cutaneous Infection by Leishmania braziliensis

    Aldina Barral;Jaqueline Guerreiro;Gloria Bomfim;D. Correia

Frequent Co-Authors

Aldina Barral
Aldina Barral Oswaldo Cruz Foundation
Cláudia Brodskyn
Cláudia Brodskyn Oswaldo Cruz Foundation
Bruno B. Andrade
Bruno B. Andrade Oswaldo Cruz Foundation
Edgar M. Carvalho
Edgar M. Carvalho Federal University of Bahia
Manuel Soto
Manuel Soto Autonomous University of Madrid
Roberto Badaró
Roberto Badaró Federal University of Bahia
João S. Silva
João S. Silva Universidade de São Paulo
Benildo Sousa Cavada
Benildo Sousa Cavada Universidade Federal do Ceará
Jesus G. Valenzuela
Jesus G. Valenzuela National Institutes of Health
Warren D. Johnson
Warren D. Johnson Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing professionals, for instance, can advance their careers by enrolling in accelerated NP programs online. These programs provide an efficient pathway to becoming a Nurse Practitioner, which can complement immunology knowledge in clinical settings.

Transitioning within nursing specializations is also common. Many nurses pursue acute care nurse practitioner programs to gain expertise in critical care, aligning well with immunological patient needs in acute environments.

For those new to healthcare, online BSN programs for non nurses offer an accessible option to enter the field, building a solid foundation relevant to immunology studies and careers.

Salary expectations vary widely but are an important consideration. Understanding how much do DNPs make can help prospective students evaluate the financial benefits of pursuing advanced degrees related to immunology and nursing.

Best Scientists Citing Manoel Barral-Netto

Trending Scientists

Recently Published Articles